UnitedHealth Group Incorporated logo

UnitedHealth Group Incorporated (UNH)

Market Closed
2 Sep, 20:00
NYSE NYSE
$
399. 66
+3.36
+0.8478%
$
364.17B Market Cap
23.04 P/E Ratio
0.16% Div Yield
3.26M Volume
22.88 Eps
$ 396.3
Previous Close
Add Transaction
Day Range
396.67 401.12
Year Range
255.97 461.62
Want to track UNH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
US Health Dept Says UnitedHealth Hack Impacted 192.7 Million Consumers' Data

US Health Dept Says UnitedHealth Hack Impacted 192.7 Million Consumers' Data

According to new data from the U.S. Department of Health and Human Services, UnitedHealth Group's data breach last year affected the personal information of 192.7 million people. The company had announced an initial estimate of 190 million in January, according to a Thursday (Aug. 14) Reuters report.

Pymnts | 1 year ago
Final Trade: UNH, BLSH, FXI, NFLX

Final Trade: UNH, BLSH, FXI, NFLX

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

Youtube | 1 year ago
Warren Buffett's Berkshire announces surprise stake in embattled UnitedHealth

Warren Buffett's Berkshire announces surprise stake in embattled UnitedHealth

The investment comes as UnitedHealth faces soaring medical costs, federal investigations, the fallout of the killing of a top executive and a cyberattack last year.

Nypost | 1 year ago
Warren Buffett's Berkshire Hathaway reveals new stake in beleaguered insurer UnitedHealth

Warren Buffett's Berkshire Hathaway reveals new stake in beleaguered insurer UnitedHealth

Warren Buffett's Berkshire Hathaway reveals new stake in beleaguered insurer UnitedHealth

Cnbc | 1 year ago
Should You Invest in UnitedHealth (UNH) Based on Bullish Wall Street Views?

Should You Invest in UnitedHealth (UNH) Based on Bullish Wall Street Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 1 year ago
Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?

Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?

UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid rising cost pressures.

Zacks | 1 year ago
UnitedHealth Is Drifting--But The Smart Money Is Buying

UnitedHealth Is Drifting--But The Smart Money Is Buying

UnitedHealth Group Incorporated is down 56% in a year — yet insiders and big funds are loading up. Q2 earnings disappointed, but new guidance and cost cuts could mark a turning point. My bearish valuation still points to nearly 30% upside for UNH from here.

Seekingalpha | 1 year ago
UnitedHealth Is In Crisis Mode - And That's When I Like To Buy

UnitedHealth Is In Crisis Mode - And That's When I Like To Buy

UNH's valuation is now quite modest after severe earnings cuts and negative headlines, offering a good margin of safety for long-term investors. The worst appears priced in; 2025 will be rough, but a recovery is expected with meaningful improvement by 2027 as margins and EPS growth normalize. Key strengths remain: scale, diversification, and Optum's value, but management must fix Medicare Advantage modeling and Optum Health profitability issues.

Seekingalpha | 1 year ago
UnitedHealth: Much Worse Than Expected

UnitedHealth: Much Worse Than Expected

UNH's Q2 earnings revealed further weakness with margins at both insurance and Optum plunging to multi-year lows while sales continued to grow at double-digits. Reestablished outlook implies no recovery in profitability during H2 with guided EPS of $16 putting shares at a ~16x fwd P/E, a 3 turn premium to peers. Admitting we have underestimated current challenges, we now see fair value around $275 considering different scenarios for FY26.

Seekingalpha | 1 year ago
UnitedHealth Group: Membership Growth Indicates Resilience Amid Rising Medical Cost Pressure

UnitedHealth Group: Membership Growth Indicates Resilience Amid Rising Medical Cost Pressure

I reiterate my bullish rating on UNH, supported by strong membership growth and innovative cost-cutting strategies like AI efficiencies and private-label initiatives. UNH is prioritizing affordability and customer retention over aggressive price hikes, leveraging AI and private-label (Nuvaila) to pass cost savings to consumers. Despite recent stock declines and rising medical costs, I project double-digit revenue growth through 2025, with significant upside potential based on valuation metrics.

Seekingalpha | 1 year ago
UnitedHealth's Fall Sets The Stage For A Contrarian Opportunity

UnitedHealth's Fall Sets The Stage For A Contrarian Opportunity

UNH's Q2 was disastrous, with missed earnings, rising medical costs, and sharply lowered guidance, deepening market pessimism and uncertainty. Despite negative headlines, the stock's valuation is now compelling, with forward P/E ratios at multi-year lows and expectations set very conservatively. UNH's structural advantages, management's reform focus, and potential for execution improvement support a contrarian, medium-term upside thesis.

Seekingalpha | 1 year ago
UnitedHealth Crashing After Q2 Shock: Should You Panic or Pounce?

UnitedHealth Crashing After Q2 Shock: Should You Panic or Pounce?

UNH plunges 12.9% after weak Q2 and slashing 2025 EPS guidance, sparking fears of deeper structural issues ahead.

Zacks | 1 year ago
Loading...
Load More